Cetera Investment Advisers’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.29M Buy
169,881
+25,187
+17% +$1.08M 0.01% 1266
2025
Q4
$6.34M Sell
144,694
-18,392
-11% -$761K 0.01% 1300
2025
Q3
$6.74M Buy
163,086
+28,147
+21% +$1.13M 0.01% 1205
2025
Q2
$5.95M Buy
134,939
+16,340
+14% +$653K 0.01% 1086
2025
Q1
$4.38M Buy
118,599
+1,925
+2% +$68.6K 0.01% 1197
2024
Q4
$3.89M Sell
116,674
-1,680
-1% -$54.5K 0.01% 1189
2024
Q3
$3.07M Buy
118,354
+88,840
+301% +$2.21M 0.01% 1304
2024
Q2
$663K Sell
29,514
-3,699
-11% -$82.1K ﹤0.01% 2382
2024
Q1
$788K Buy
33,213
+21,425
+182% +$476K ﹤0.01% 2256
2023
Q4
$283K Sell
11,788
-213
-2% -$4.63K ﹤0.01% 1815
2023
Q3
$262K Buy
12,001
+299
+3% +$6.25K ﹤0.01% 1820
2023
Q2
$224K Buy
11,702
+99
+0.9% +$1.91K ﹤0.01% 1919
2023
Q1
$225K Sell
11,603
-960
-8% -$16.7K ﹤0.01% 1887
2022
Q4
$202K Buy
12,563
+2,351
+23% +$38.3K ﹤0.01% 1900
2022
Q3
$160K Buy
+10,212
New +$197K ﹤0.01% 1528

Other funds holding EXEL

Cetera Investment Advisers's EXEL Position: Q1 2026 in Review

Cetera Investment Advisers increased its Exelixis (EXEL) stake by 17% in Q1 2026, buying an estimated $1.08M and bringing the position to 169,881 shares worth $7.29M. The position accounts for 0.01% of the portfolio, ranked #1266.

Cetera Investment Advisers first reported a position in EXEL in Q3 2022 and has held it in 15 quarters since. 694 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.

  • Cetera Investment Advisers held 169,881 shares of Exelixis worth $7.29M as of Q1 2026.
  • Cetera Investment Advisers bought 25,187 Exelixis shares in Q1 2026, an estimated $1.08M.
  • Exelixis made up 0.01% of Cetera Investment Advisers's portfolio in Q1 2026, its #1266 holding.
  • Cetera Investment Advisers first reported a position in Exelixis in Q3 2022 and has held it in 15 quarters since.
  • 694 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.